Meningococcal Infection

Generalities
Agent	Bacteria: Neisseria meningitidis (meningococcus), Gram negative diplococci - 12 serogroups have been identified - Six serogrouprs are responsible of invasive infection: A, B, C, W135, X, and Y.
Incubation period	2-10 days, commonly 3-4 days
Period of transmissibility	Cases should be considered infectious from exposure until 24 hours after starting treatment of prophylaxis with appropriate antibiotics with substantial concentrations in oro/nasopharyngeal secretions
Reservoir	- Humans - Asymptomatic carriage in nasopharynx is common.
Modes of transmission	- Person-to-person transmission by direct contact with respiratory droplets of infected people - Most cases acquired through exposure to asymptomatic carriers
Clinical presentation	- Bacterial meningitis - Septicaemia: rare ans severe with purpura - Complications: cerebral lesions, hearing loss, learning disorders among 10-20% of survivors - Case fatality: 8-15% despite treatment
Resources
Case definition	- MOPH circular no. 63 (2007) - MOPH circular no. 72 (2003): contacts
Forms	- Meningitis reporting form - Meningitis investigation form
Data	- Weekly report

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D11AX01	REGAINE FOAM FOR MEN	B	Minoxidil - 5%		Foam	3,090,838 L.L
D06BA51	IALUGEN PLUS	B	Silver sulfadiazine - 10mg/g, Sodium hyaluronate - 0.5mg/g		Gauze	1,463,444 L.L
A01AB09	DAKTARIN ORAL	B	Miconazole nitrate - 20mg/g	20mg/g	Gel	377,620 L.L
A01AB09	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	229,093 L.L
A01AB09	MICOZOLE	G	Miconazole - 20mg/g	20mg/g	Gel	104,820 L.L
A01AB09	MYCOHEAL	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	210,983 L.L
D10AD03	DIFADERM	G	Adapalene - 0.1%	0.1%	Gel	414,671 L.L
D10AD03	DIFFERIN	B	Adapalene - 0.1g/100g	0.1%	Gel	503,941 L.L
D10AD03	DIFADERM	G	Adapalene - 0.3%	0.3%	Gel	952,208 L.L
D10AD04	ROACCUTANE	B	Isotretinoin - 0.05%	0.05%	Gel	932,627 L.L
D10AD51	ERYLIK	G	Tretinoin - 0.025%, Erythromycin - 4%		Gel	378,964 L.L
D10AD51	RETINOMYCIN	G	Tretinoin - 0.025%, Erythromycin - 4%		Gel	662,962 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
C05AE03	DILTIGEL	G	Diltiazem HCl - 2%	2%	Gel	632,950 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
D10AD53	EPIDUO	B	Adapalene - 0.1%, Benzoyl peroxide - 2.5%		Gel	2,088,331 L.L
C05BA53	CONTRACTUBEX	B	Allantoin - 1g/100g, Cepae - 10g/100g, Heparin - 5000IU/100g		Gel	498,566 L.L
D10AD53	EPIDUO FORTE	B	Adapalene - 0.3%, Benzoyl peroxide - 2.5%		Gel	2,201,214 L.L
C05BA53	CONTRACTUBEX	B	Allantoin - 1g/100g, Cepae - 10g/100g, Heparin - 5,000IU/100g		Gel	1,183,925 L.L
D10AE01	BENZAC AC	G	Benzoyl peroxide - 10g/100g	10%	Gel	416,591 L.L
D10AE01	BENZAC AC	G	Benzoyl peroxide - 5g/100g	5%	Gel	388,370 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
D10AF02	SPOTEX	G	Erythromycin - 4%	4%	Gel	854,684 L.L
S01AD09	VIRGAN	B	Ganciclovir - 1.5mg/g	1.5mg/g	Gel	804,962 L.L
D10AF05	NAXIDERM	G	Nadifloxacin - 1%	1%	Gel	826,783 L.L
S01AD09	GANVIR	G	Ganciclovir - 0.15%	0.15%	Gel	698,798 L.L
D10AF51	DUAC ONCE DAILY	B	Clindamycin (phosphate) - 1%, Benzoyl peroxide - 5%		Gel	1,658,302 L.L
C05CA05	VENOSMIL	G	Hidrosmin - 2%	2%	Gel	588,603 L.L